Absence of susceptibility vessel sign is associated with aspiration-resistant fibrin/platelet-rich thrombi.


Journal

International journal of stroke : official journal of the International Stroke Society
ISSN: 1747-4949
Titre abrégé: Int J Stroke
Pays: United States
ID NLM: 101274068

Informations de publication

Date de publication:
10 2021
Historique:
pubmed: 14 1 2021
medline: 12 11 2021
entrez: 13 1 2021
Statut: ppublish

Résumé

The composition of the thrombus influences its retrievability by mechanical thrombectomy. Our study aimed to report on thrombi resistant to aspiration, regarding susceptibility vessel sign and histologic composition. This observational study was based on a prospective database of acute anterior circulation ischemic strokes treated by mechanical thrombectomy. Endovascular first-line strategy was aspiration and in case of failure, combined therapy-rescue was performed. The positivity of susceptibility vessel sign (SVS+) or its negativity (SVS-) was assessed on T2* sequences. The thrombus composition was analyzed with hematoxylin eosin staining. Histological analysis was performed on 102 clots. Thrombi with SVS- were significantly richer in fibrin/platelets, p = 0.04. Out of 210 mechanical thrombectomy, aspiration first pass strategy was performed in 131/210 (62%) patients. Combined therapy-rescue was needed in 37% of aspiration first pass strategy cases ( Our results confirm that SVS- clots are rich in fibrin/platelets and suggest that these "white clots" are less likely to be retrieved by aspiration alone and more often require the use of combined therapy.

Sections du résumé

BACKGROUND
The composition of the thrombus influences its retrievability by mechanical thrombectomy.
PURPOSE
Our study aimed to report on thrombi resistant to aspiration, regarding susceptibility vessel sign and histologic composition.
METHODS
This observational study was based on a prospective database of acute anterior circulation ischemic strokes treated by mechanical thrombectomy. Endovascular first-line strategy was aspiration and in case of failure, combined therapy-rescue was performed. The positivity of susceptibility vessel sign (SVS+) or its negativity (SVS-) was assessed on T2* sequences. The thrombus composition was analyzed with hematoxylin eosin staining.
RESULTS
Histological analysis was performed on 102 clots. Thrombi with SVS- were significantly richer in fibrin/platelets, p = 0.04. Out of 210 mechanical thrombectomy, aspiration first pass strategy was performed in 131/210 (62%) patients. Combined therapy-rescue was needed in 37% of aspiration first pass strategy cases (
CONCLUSIONS
Our results confirm that SVS- clots are rich in fibrin/platelets and suggest that these "white clots" are less likely to be retrieved by aspiration alone and more often require the use of combined therapy.

Identifiants

pubmed: 33435860
doi: 10.1177/1747493020986626
doi:

Substances chimiques

Fibrin 9001-31-4

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

972-980

Auteurs

Jean Darcourt (J)

Department of Neuroradiology, CHU of Toulouse, France.
INSERM 333461I2MC (Institut des Maladies Cardiovasculaires et Métaboliques) UMR 1048, Toulouse University Hospital, Toulouse, France.

Cédric Garcia (C)

INSERM 333461I2MC (Institut des Maladies Cardiovasculaires et Métaboliques) UMR 1048, Toulouse University Hospital, Toulouse, France.
Laboratory of Hematology, CHU of Toulouse, France.

Do M Phuong (DM)

Internal Medicine, CHU of Toulouse, France.

Caterina Michelozzi (C)

Department of Neuroradiology, CHU of Toulouse, France.

Guillaume Bellanger (G)

Department of Neuroradiology, CHU of Toulouse, France.

Gilles Adam (G)

Department of Neuroradiology, CHU of Toulouse, France.

Margaux Roques (M)

Department of Neuroradiology, CHU of Toulouse, France.

Anne C Januel (AC)

Department of Neuroradiology, CHU of Toulouse, France.

Philippe Tall (P)

Department of Neuroradiology, CHU of Toulouse, France.

Jean F Albucher (JF)

Department of Vascular Neurology, CHU of Toulouse, France.

Jean M Olivot (JM)

Department of Vascular Neurology, CHU of Toulouse, France.

Fabrice Bonneville (F)

Department of Neuroradiology, CHU of Toulouse, France.

Bernard Payrastre (B)

INSERM 333461I2MC (Institut des Maladies Cardiovasculaires et Métaboliques) UMR 1048, Toulouse University Hospital, Toulouse, France.
Laboratory of Hematology, CHU of Toulouse, France.

Christophe Cognard (C)

Department of Neuroradiology, CHU of Toulouse, France.
INSERM 333461I2MC (Institut des Maladies Cardiovasculaires et Métaboliques) UMR 1048, Toulouse University Hospital, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH